0 citations0 references

Iranian Journal of Cancer Prevention

Iranian Journal of Cancer Prevention2017

Citations Over Time

Ahmad Faramarzi, Rajabali Daroudi, Azin Nahvijou, Ali Akbari Sari, Mohammad Arab, Bita Kalaghchi, L Li, C Zhang, X Li, S Lu, Y Zhou, T Li, Q Suo, D He, W Du, M Yang, X Fan, F Bray, J Ferlay, I Soerjomataram, R Siegel, L Torre, A Jemal, A Jemal, R Siegel, J Xu, E Ward, S Mirinezhad, M Somi, A Jangjoo, F Seyednezhad, S Dastgiri, M Mohammadzadeh, H Zeng, R Zheng, Y Guo, S Zhang, X Zou, N Wang, H Kim, M Puymon, M Qin, K Guru, J Mohler, M Martin-Richard, Diaz Beveridge, R Arrazubi, V Alsina, M, Galan Guzman, M Custodio, A, L Gordon, N Hirst, G Mayne, D Watson, T Bright, W Cai, R Arlow, D Moore, C Chen, J Langenfeld, D August, J Chen, Y Lin, W Cai, T Su, B Wang, J Li, P Mcnamee, J Seymour, A Garber, H Sox, N Silva-Illanes, M Espinoza, C Lao, C Brown, P Rouse, R Edlin, R Lawrenson, G Harewood, M Wiersema, H Pohl, A Sonnenberg, S Strobel, A Eckardt, T Rosch, J Chu, J Choi, A Tramontano, C Morse, D Forcione, N Nishioka, C Lin, H Fang, C Feng, C Li, C Chien, Fong Soe Khioe, R Skedgel, C Hart, A Lewis, Mpn Alexandre, L, A Webb, D Cunningham, J Scarffe, P Harper, A Norman, J Joffe, V Janmaat, M Bruno, S Polinder, S Lorenzen, F Lordick, M Peppelenbosch, J Shenfine, P Mcnamee, N Steen, J Bond, S Griffin, U Wenger, E Johnsson, H Bergquist, J Nyman, H Ejnell, J Lagergren, D Xinopoulos, D Dimitroulopoulos, K Tsamakidis, D Korkolis, A Fotopoulou, A Bazinis, Da Silveira, E, Artifon El, L Lee, M Sudarshan, C Li, E Latimer, G Fried, D Mulder, S Kim, J Park, S Kim, H Woo, J Park, Y Kim, I Harirchi, S Kolahdoozan, S Hajizadeh, F Safari, Z Sedighi, A Nahvijou, P Song, H Liang, J Fan, W Wei, G Wang, Y Qiao, P Mccann, T Stafinski, C Wong, D Menon, D Nelson, R Dhupar, R Katkhuda, A Correa, A Goltsov, D Maru, S Sanghera, J Coast, R Martin, J Donovan, S Mohiuddin, A Rashidian, E Barfar, H Hosseini, S Nosratnejad, E Barooti, V Becerra, M Avila, J Jimenez, L Cortes-Sanabria, Y Pardo, O Garin, A Nahvijou, M Hadji, A Marnani, F Tourang, N Bayat, E Weiderpass, H Allgayer, I Davini, P Becagli, M Pani, S Trippoli, D Peverini, A Messori, G Dimofte, F Crumpei, L Trifina, S Nicolescu, D Leanca

Abstract

Context: Esophageal cancer is considered as a malignant disease with fatal consequences worldwide.In cancers, it is the sixth most common cause of mortality in the world. Objectives:The aim of the current study was to assess the cost-effectiveness of esophageal cancer treatments by performing a systematic review. Data Sources:We conducted systematic searches in Medline through PubMed, Scopus, Cochran Library, EMBASE, and Web of Science databases.The search was limited to English language publications and studies published before July 17, 2018.Results: Of 2487 records, 14 articles met our inclusion criteria.Most were conducted in The United States of America (USA) and The United Kingdom (UK).The majority of the evaluations (8) followed a healthcare system perspective.Of 14 included studies, 4 compared esophagectomy with endoscopy treatment (ET), 2 compared esophagectomy with chemotherapy regimens, 2 contrasted chemotherapy regimens, and 5 studied compared palliative cares.Conclusions: Among all the assessed studies, the ET was more cost-effective than esophagectomy, but there were contradictory results in palliative care for the treatment of esophageal cancer.

Citations Over Time

Abstract

Related Papers